Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026)
Beyond Air (XAIR) posted Liabilities and Shareholders Equity of $35.4 million for Q1 2026, down 3.78% sequentially from $36.8 million in Q4 2025, and up 17.71% YoY from $30.1 million in Q1 2025.
Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
Beyond Air has reported Liabilities and Shareholders Equity for 12 years, with the latest figure at $35.4 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 17.71% year-over-year to $35.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.2 million (down 19.84% YoY) and the FY2026 annual result came in at $35.4 million, up 17.71% from the prior year.
- Liabilities and Shareholders Equity retreated to $35.4 million in Q1 2026 per XAIR's latest filing, from $36.8 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $99.2 million in Q1 2022 and troughed at $28.1 million in Q2 2025.
- A 5-year average of $55.9 million and a median of $53.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity soared 144.78% in 2022, then sank 47.22% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $74.0 million in 2022, then decreased by 29.81% to $51.9 million in 2023, then plunged by 34.23% to $34.1 million in 2024, then climbed by 7.7% to $36.8 million in 2025, then decreased by 3.78% to $35.4 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $35.4 million, $36.8 million, and $31.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Beyond Air | 3.72 Mn | -7.19 Mn | 225,000.00 | 32.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.89 Mn |
| Mar 31, 2026 | 35.39 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Sep 30, 2025 | 30.97 Mn |
| Jun 30, 2025 | 28.11 Mn |
| Mar 31, 2025 | 30.06 Mn |
| Dec 31, 2024 | 34.14 Mn |
| Sep 30, 2024 | 53.01 Mn |
| Jun 30, 2024 | 46.50 Mn |
| Mar 31, 2024 | 56.96 Mn |
| Dec 31, 2023 | 51.91 Mn |
| Sep 30, 2023 | 58.01 Mn |
| Jun 30, 2023 | 73.04 Mn |
| Mar 31, 2023 | 68.75 Mn |
| Dec 31, 2022 | 73.96 Mn |
| Sep 30, 2022 | 82.04 Mn |
| Jun 30, 2022 | 91.90 Mn |
| Mar 31, 2022 | 99.20 Mn |
| Dec 31, 2021 | 99.31 Mn |
| Sep 30, 2021 | 54.06 Mn |